1. PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. (23rd June 2022) Authors: Giatra, C.; Souravla, E.; Darmani, I.; Roumelioti, A.; Kaouranis, K.; Kosmas, P.; Bampali, V.; Gardeli, D.; Papageorgiou, M.; Mellios, Z.; Karaolidou, F.; Tsonis, I.; Karatza, M.; George, K.; Marinos, L.; Karakasis, D.; Karmiris, T.; Bakiri, M.; Bouzani, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1971 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗